Core Viewpoint - Medtronic has appointed Kate Benedict as the Senior Vice President and President of the Acute Care & Monitoring (ACM) division, marking a strategic shift in response to market changes and aiming for growth in the healthcare sector [6][15]. Summary by Sections Appointment of Kate Benedict - Kate Benedict brings over 25 years of experience in the medical industry, with a focus on medical devices, diagnostics, pharmaceuticals, and drug delivery [4]. - She has held leadership roles at Flex, BD, Alcon, and Johnson & Johnson, demonstrating a strong background in driving innovation and market growth [5]. Recent Changes at Medtronic - Medtronic has undergone significant personnel changes, including the departure of key executives and the restructuring of its ACM division [7][8]. - The company decided to integrate its patient monitoring and respiratory intervention businesses into the new ACM division instead of divesting them, which had previously been valued at $9 billion [8][11]. Market Dynamics and Strategic Focus - The ACM market has seen substantial changes, particularly due to the decline in demand for ventilators post-COVID-19, prompting Medtronic to focus on high-growth monitoring technologies [11]. - The ACM division's product line includes pulse oximeters, remote patient monitoring, airway management, and respiratory monitoring products, aimed at meeting new market demands [11][13]. Financial Outlook - Medtronic's revenue for fiscal year 2024 was $32.4 billion, with the medical surgical portfolio, including ACM, accounting for approximately 26% of this revenue [11]. - The ACM division is positioned within a $100 billion market potential, particularly in chronic disease management and post-operative care, seen as a growth engine for the company [11]. Recent Developments - In April 2025, Medtronic entered a distribution agreement with Retia Medical to introduce the Argos™ cardiac output monitor, enhancing its monitoring capabilities in the ACM field [14].